Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Anorexia Nervosa
NCT04661514Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of psilocybin in anorexia nervosa (AN), sponsored by University of California, San Diego. Primary endpoints: Incidence and occurrence of changes in Adverse Events, Incidence of clinically important changes in ECG parameters and 3 more. Started May 2021; status: completed.
02
Drugs
psilocybin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04661514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04661514.